Clovis Oncology Inc (NASDAQ:CLVS)

2.76
Delayed Data
As of Dec 03
 -0.35 / -11.25%
Today’s Change
2.75
Today|||52-Week Range
11.10
-42.50%
Year-to-Date

Today’s Trading

Previous close3.11
Today’s open3.10
Day’s range2.75 - 3.10
Volume306,651
Average volume (3 months)3,098,545
Market cap$401.6M
Data as of 3:59pm ET, 12/03/2021

Growth & Valuation

Earnings growth (last year)+41.08%
Earnings growth (this year)+47.40%
Earnings growth (next 5 years)+86.83%
Revenue growth (last year)+15.05%
P/E ratioNM
Price/Sales2.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
WWHCW World Corp0.000.00%
----
ACIUAC Immune SA-0.17-3.39%
IPHAInnate Pharma SA-0.38-8.02%
Data as of 3:59pm ET, 12/03/2021

Financials

Next reporting dateFebruary 23, 2022
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$164.5M
Annual profit (last year)-$369.2M
Net profit margin-224.41%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Boulder, Colorado

Forecasts